These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15056235)

  • 1. Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months.
    Maeda T; Shintani Y; Nakano K; Terashima K; Yamada Y
    Pediatr Int; 2004 Apr; 46(2):122-5. PubMed ID: 15056235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect of inactivated influenza vaccine on young children.
    Maeda T; Shintani Y; Miyamoto H; Kawagoe H; Nakano K; Nishiyama A; Yamada Y
    Pediatr Int; 2002 Feb; 44(1):43-6. PubMed ID: 11982870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oil-in-water emulsion adjuvant with influenza vaccine in young children.
    Vesikari T; Knuf M; Wutzler P; Karvonen A; Kieninger-Baum D; Schmitt HJ; Baehner F; Borkowski A; Tsai TF; Clemens R
    N Engl J Med; 2011 Oct; 365(15):1406-16. PubMed ID: 21995388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM;
    N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study.
    Heinonen S; Silvennoinen H; Lehtinen P; Vainionpää R; Ziegler T; Heikkinen T
    Lancet Infect Dis; 2011 Jan; 11(1):23-9. PubMed ID: 21106443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.
    Katayose M; Hosoya M; Haneda T; Yamaguchi H; Kawasaki Y; Sato M; Wright PF
    Vaccine; 2011 Feb; 29(9):1844-9. PubMed ID: 21195802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
    Fu C; Xu J; Lin J; Wang M; Li K; Ge J; Thompson MG
    Vaccine; 2015 Jun; 33(25):2917-21. PubMed ID: 25921713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo ST; Giesick JS; Ginsberg MM; Cox NJ
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine for prevention of mild and moderate-to-severe influenza in children.
    Jain VK; Rivera L; Zaman K; Espos RA; Sirivichayakul C; Quiambao BP; Rivera-Medina DM; Kerdpanich P; Ceyhan M; Dinleyici EC; Cravioto A; Yunus M; Chanthavanich P; Limkittikul K; Kurugol Z; Alhan E; Caplanusi A; Durviaux S; Boutet P; Ofori-Anyinam O; Chandrasekaran V; Dbaibo G; Innis BL
    N Engl J Med; 2013 Dec; 369(26):2481-91. PubMed ID: 24328444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children.
    Ozgur SK; Beyazova U; Kemaloglu YK; Maral I; Sahin F; Camurdan AD; Kizil Y; Dinc E; Tuzun H
    Pediatr Infect Dis J; 2006 May; 25(5):401-4. PubMed ID: 16645502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months.
    Hwang KP; Hsu YL; Hsieh TH; Lin HC; Yen TY; Wei HM; Lin HC; Chen AC; Chow JC; Huang LM
    Vaccine; 2014 May; 32(21):2469-73. PubMed ID: 24625341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine in healthy preschool children.
    Colombo C; Argiolas L; La Vecchia C; Negri E; Meloni G; Meloni T
    Rev Epidemiol Sante Publique; 2001 Apr; 49(2):157-62. PubMed ID: 11319482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A
    Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.